To analyze the change in the local immune cells, mice bearing 10-day established ID8 tumor were treated with either single or combined anti-PD-1/CD137 mAbs and their peritoneal lavages were harvested 7 days after the last mAb injection. Here, TNFRSF9 is linked to neoplasm.